Viewing StudyNCT02448420



Ignite Creation Date: 2024-05-06 @ 4:03 AM
Last Modification Date: 2024-10-26 @ 11:43 AM
Study NCT ID: NCT02448420
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2015-05-08

Brief Title: Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Sponsor:
Organization: SOLTI Breast Cancer Research Group

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 73
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: